Kevin J. Kenny Sells 3,876 Shares of Orthofix Medical Inc. (NASDAQ:OFIX) Stock

Orthofix Medical Inc. (NASDAQ:OFIX – Get Rating) insider Kevin J. Kenny sold 3,876 shares of the stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $19.00, for a total transaction of $73,644.00. Following the sale, the insider now directly owns 142,431 shares in the company, valued at $2,706,189. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Orthofix Medical Trading Down 0.4 %

OFIX stock traded down $0.08 during midday trading on Friday, reaching $18.86. The company’s stock had a trading volume of 161,286 shares, compared to its average volume of 340,905. Orthofix Medical Inc. has a 52 week low of $13.76 and a 52 week high of $27.91. The stock has a market cap of $689.14 million, a PE ratio of -7.61 and a beta of 0.87. The company has a quick ratio of 1.37, a current ratio of 2.98 and a debt-to-equity ratio of 0.10. The business’s 50-day simple moving average is $17.95 and its 200-day simple moving average is $19.02.

Orthofix Medical (NASDAQ:OFIX – Get Rating) last announced its quarterly earnings data on Monday, March 6th. The medical device company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.56. Orthofix Medical had a negative net margin of 14.40% and a negative return on equity of 2.14%. The firm had revenue of $122.23 million for the quarter, compared to analysts’ expectations of $121.90 million. During the same period last year, the firm earned $0.27 earnings per share. As a group, sell-side analysts expect that Orthofix Medical Inc. will post -2.89 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on shares of Orthofix Medical in a research note on Sunday, May 21st. They issued a “buy” rating on the stock.

Institutional Investors Weigh In On Orthofix Medical

Several hedge funds have recently bought and sold shares of OFIX. Quantbot Technologies LP acquired a new stake in Orthofix Medical in the first quarter worth $39,000. CWM LLC raised its holdings in Orthofix Medical by 433.4% in the fourth quarter. CWM LLC now owns 1,947 shares of the medical device company’s stock worth $40,000 after purchasing an additional 1,582 shares during the period. KBC Group NV raised its holdings in Orthofix Medical by 87.1% in the first quarter. KBC Group NV now owns 2,879 shares of the medical device company’s stock worth $48,000 after purchasing an additional 1,340 shares during the period. UBS Group AG raised its holdings in Orthofix Medical by 2,120.8% in the third quarter. UBS Group AG now owns 2,776 shares of the medical device company’s stock worth $53,000 after purchasing an additional 2,651 shares during the period. Finally, US Bancorp DE acquired a new stake in Orthofix Medical in the third quarter worth $57,000. 98.43% of the stock is currently owned by institutional investors and hedge funds.

About Orthofix Medical

(Get Rating)

Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.